These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11340302)

  • 1. Inhibition of TNF-alpha, induced cytokine and adhesion molecule. Expression in glomerular cells in vitro and in vivo by transcription factor decoy for NFkappaB.
    Tomita N; Morishita R; Tomita S; Kaneda Y; Higaki J; Ogihara T; Horiuchi M
    Exp Nephrol; 2001; 9(3):181-90. PubMed ID: 11340302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factor decoy for NFkappaB inhibits TNF-alpha-induced cytokine and adhesion molecule expression in vivo.
    Tomita N; Morishita R; Tomita S; Gibbons GH; Zhang L; Horiuchi M; Kaneda Y; Higaki J; Ogihara T; Dzau VJ
    Gene Ther; 2000 Aug; 7(15):1326-32. PubMed ID: 10918504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcription factor decoy for NFkappaB inhibits cytokine and adhesion molecule expressions in synovial cells derived from rheumatoid arthritis.
    Tomita T; Takano H; Tomita N; Morishita R; Kaneko M; Shi K; Takahi K; Nakase T; Kaneda Y; Yoshikawa H; Ochi T
    Rheumatology (Oxford); 2000 Jul; 39(7):749-57. PubMed ID: 10908694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice.
    Kawamura I; Morishita R; Tsujimoto S; Manda T; Tomoi M; Tomita N; Goto T; Ogihara T; Kaneda Y
    Gene Ther; 2001 Jun; 8(12):905-12. PubMed ID: 11426330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral injection of oligonucleotides to the NF kappa B binding site inhibits cachexia in a mouse tumor model.
    Kawamura I; Morishita R; Tomita N; Lacey E; Aketa M; Tsujimoto S; Manda T; Tomoi M; Kida I; Higaki J; Kaneda Y; Shimomura K; Ogihara T
    Gene Ther; 1999 Jan; 6(1):91-7. PubMed ID: 10341880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo administration of a nuclear transcription factor-kappaB decoy suppresses experimental crescentic glomerulonephritis.
    Tomita N; Morishita R; Lan HY; Yamamoto K; Hashizume M; Notake M; Toyosawa K; Fujitani B; Mu W; Nikolic-Paterson DJ; Atkins RC; Kaneda Y; Higaki J; Ogihara T
    J Am Soc Nephrol; 2000 Jul; 11(7):1244-1252. PubMed ID: 10864580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of abdominal aortic aneurysms by simultaneous inhibition of NFkappaB and ets using chimeric decoy oligonucleotides in a rabbit model.
    Miyake T; Aoki M; Nakashima H; Kawasaki T; Oishi M; Kataoka K; Tanemoto K; Ogihara T; Kaneda Y; Morishita R
    Gene Ther; 2006 Apr; 13(8):695-704. PubMed ID: 16397509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressed severity of collagen-induced arthritis by in vivo transfection of nuclear factor kappaB decoy oligodeoxynucleotides as a gene therapy.
    Tomita T; Takeuchi E; Tomita N; Morishita R; Kaneko M; Yamamoto K; Nakase T; Seki H; Kato K; Kaneda Y; Ochi T
    Arthritis Rheum; 1999 Dec; 42(12):2532-42. PubMed ID: 10615998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcription factor decoy for nuclear factor-kappaB inhibits tumor necrosis factor-alpha-induced expression of interleukin-6 and intracellular adhesion molecule-1 in endothelial cells.
    Tomita N; Morishita R; Tomita S; Yamamoto K; Aoki M; Matsushita H; Hayashi S; Higaki J; Ogihara T
    J Hypertens; 1998 Jul; 16(7):993-1000. PubMed ID: 9794740
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaspin inhibited proinflammatory cytokine induced activation of nuclear factor-kappa B and its downstream molecules in human endothelial EA.hy926 cells.
    Liu S; Dong Y; Wang T; Zhao S; Yang K; Chen X; Zheng C
    Diabetes Res Clin Pract; 2014 Mar; 103(3):482-8. PubMed ID: 24418398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of intimal hyperplasia after balloon injury in rat carotid artery model using cis-element 'decoy' of nuclear factor-kappaB binding site as a novel molecular strategy.
    Yoshimura S; Morishita R; Hayashi K; Yamamoto K; Nakagami H; Kaneda Y; Sakai N; Ogihara T
    Gene Ther; 2001 Nov; 8(21):1635-42. PubMed ID: 11895002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rac1 and superoxide are required for the expression of cell adhesion molecules induced by tumor necrosis factor-alpha in endothelial cells.
    Chen XL; Zhang Q; Zhao R; Ding X; Tummala PE; Medford RM
    J Pharmacol Exp Ther; 2003 May; 305(2):573-80. PubMed ID: 12606638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of nuclear factor-kappaB decoy transfection on nuclear factor-kappaB activity and vascular endothelial growth factor/urokinase-type plasminogen activator/intercellular cell adhesion molecule-1 level of SKOV3 cells].
    Lu JP; Sun H; Cao CC; Ou ZL
    Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):533-7. PubMed ID: 15363352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of NF-κB decoy oligodeoxynucleotide on LPS/high-fat diet-induced atherosclerosis in an animal model.
    Kim SJ; Park JH; Kim KH; Lee WR; Lee S; Kwon OC; Kim KS; Park KK
    Basic Clin Pharmacol Toxicol; 2010 Dec; 107(6):925-30. PubMed ID: 20649557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo transfection of NF-kappaB decoy oligodeoxynucleotides attenuate renal ischemia/reperfusion injury in rats.
    Cao CC; Ding XQ; Ou ZL; Liu CF; Li P; Wang L; Zhu CF
    Kidney Int; 2004 Mar; 65(3):834-45. PubMed ID: 14871403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NFkappaB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts.
    Vos IH; Govers R; Gröne HJ; Kleij L; Schurink M; De Weger RA; Goldschmeding R; Rabelink TJ
    FASEB J; 2000 Apr; 14(5):815-22. PubMed ID: 10744638
    [TBL] [Abstract][Full Text] [Related]  

  • 17. cis Element decoy against nuclear factor-kappaB attenuates development of experimental autoimmune myocarditis in rats.
    Yokoseki O; Suzuki J; Kitabayashi H; Watanabe N; Wada Y; Aoki M; Morishita R; Kaneda Y; Ogihara T; Futamatsu H; Kobayashi Y; Isobe M
    Circ Res; 2001 Nov; 89(10):899-906. PubMed ID: 11701617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of NFkappaB activation using cis-element 'decoy' of NFkappaB binding site reduces neointimal formation in porcine balloon-injured coronary artery model.
    Yamasaki K; Asai T; Shimizu M; Aoki M; Hashiya N; Sakonjo H; Makino H; Kaneda Y; Ogihara T; Morishita R
    Gene Ther; 2003 Feb; 10(4):356-64. PubMed ID: 12595894
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory effects of NFkappaB decoy oligodeoxynucleotides on neointimal hyperplasia in a rabbit vein graft model.
    Miyake T; Aoki M; Shiraya S; Tanemoto K; Ogihara T; Kaneda Y; Morishita R
    J Mol Cell Cardiol; 2006 Sep; 41(3):431-40. PubMed ID: 16762361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ginsenoside Rg3 inhibits tumor necrosis factor-alpha-induced expression of cell adhesion molecules in human endothelial cells.
    Hien TT; Kim ND; Kim HS; Kang KW
    Pharmazie; 2010 Sep; 65(9):699-701. PubMed ID: 21038849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.